MTOR and cancer: Human cancer cells exposed to different concentrations of CT showed inhibition of major signaling pathways that are involved in multiple cellular processes such as, mammalian target of rapamycin (mTOR) in hepatic [30], gastric [30], pancreatic [34], soft sarcoma [38] and prostate [38] cancer.